Nexgel (NXGL) P/E (2021 - 2026)
Nexgel (NXGL) P/E from Dec 22, 2021 to Jul 21, 2026. The TTM Nexgel (NXGL) P/E is -1.10. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Nexgel (NXGL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.10 | -74.12% |
| 2025 | -4.26 | -53.34% |
| 2024 | -9.13 | +104.94% |
| 2023 | -4.45 | +267.11% |
| 2022 | -1.21 | -45.28% |
| 2021 | -2.22 | N/A |
Comparison Nexgel (NXGL) P/E with competitors
Nexgel (NXGL) P/E is -1.10.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -120.31% |
| EMBC | Embecta Corp | 1.69 | -253.33% |
| SOLV | Solventum Corp | 9.49 | -961.08% |
| ZJYL | Jin Medical International Ltd | 12.75 | -1256.35% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -1480.65% |
| RMD | Resmed Inc | 19.04 | -1827.71% |
| UTMD | Utah Medical Products Inc | 20.76 | -1983.26% |
| ATR | Aptargroup Inc | 21.65 | -2063.77% |
| ALGN | Align Technology Inc | 30.29 | -2847.97% |
| HOLX | Hologic Inc | 30.86 | -2899.89% |
| MMSI | Merit Medical Systems Inc | 31.15 | -2925.49% |
| STVN | Stevanato Group Spa | 31.25 | -2935.28% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -3396.70% |
| ALC | Alcon Inc | 41.51 | -3866.11% |
| ISRG | Intuitive Surgical Inc | 46.43 | -4311.75% |
| BDX | Becton Dickinson & Company | 46.93 | -4357.53% |
| WST | West Pharmaceutical Services Inc | 47.41 | -4400.68% |
| NEPH | Nephros Inc | 50.00 | -4635.53% |
| COO | Cooper Companies Inc | 58.98 | -5450.35% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -5742.54% |
| NVST | Envista Holdings Corp | 64.66 | -5966.12% |
| BAX | Baxter International Inc | 72.66 | -6691.17% |
| ICUI | ICU Medical Inc | 84.82 | -7794.66% |
| RGEN | Repligen Corp | 162.20 | -14814.03% |
| WRBY | Warby Parker Inc - Class A | 318.30 | -28975.15% |